Interpace Biosciences, Inc. Gains 39.23%
Thu, Jul 02, 2020 at 05:30 PM
Interpace Biosciences, Inc. (IDXG:NASDAQ) shot up at $6.14, a gain of 39.2%. On Wed 01 Jul 20, IDXG:NASDAQ hit a New 2-Week Low of $4.41. The stock got featured on our News Catalysts scanner on Thu 25 Jun 20 at 05:12 PM in the 'EARNINGS' category. From Wed 17 Jun 20, the stock recorded 40.00% Up Days and 27.27% Green Days
The share price of the company has been moving sideways in recent weeks.
About Interpace Biosciences, Inc. (IDXG:NASDAQ)
Interpace Diagnostics Group Inc is engaged in developing and commercializing molecular diagnostic tests, leveraging the latest technology and personalized medicine for diagnosis and management.
Top 10 Gainers:
- GEE Group, Inc. (JOB:NYSEMKT), 192.11%
- Genius Brands International, Inc. (GNUS:NASDAQ), 53.68%
- Graf Industrial Corp. (GRAF:NYSE), 48.23%
- Francesca's Holdings Corporation (FRAN:NASDAQ), 42.65%
- Interpace Biosciences, Inc. (IDXG:NASDAQ), 39.23%
- Broadway Financial Corporation (BYFC:NASDAQ), 37.61%
- Origin Agritech Limited (SEED:NASDAQ), 34.84%
- Electrameccanica Vehicles Corp. (SOLO:NASDAQ), 34.33%
- Staffing 360 Solutions, Inc. (STAF:NASDAQ), 30.49%
- Eltek Ltd. (ELTK:NASDAQ), 29.63%